Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04381793 · ClinicalTrials.gov registry record · NA
Treatment of CFS & Fibromyalgia With Recovery Factors
A NA study, sponsored by Practitioners Alliance Network.
- Completed
- Registry status
- NA
- Development phase
- 43
- Enrollment target
NCT04381793: Completed NA study, sponsored by Practitioners Alliance Network.
NCT04381793 is a NA study that has completed, run by Practitioners Alliance Network. The registered enrollment target is 43 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (97% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04381793, a NA study, has completed, sponsored by Practitioners Alliance Network.
- COMPLETED
- Registry status
- NA
- Development phase
- 43 participants
- Enrollment target
Study Summary
The study will explore if Recovery Factors improve symptoms in fibromyalgia and chronic fatigue syndrome
Primary Outcome
Composite VAS (1-10) for Fatigue, Pain, Cognition, Sleep and overall well-being
Interventions
- DIETARY_SUPPLEMENT Recovery Factors
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 43 participants |
| Start Date | 2019-05-20 |
| Est. Completion | 2020-07-04 |
| Phase | NA |
What the finished NCT04381793 record still lists
NCT04381793 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 43 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (97% lower).
The record links to 0 conditions, and to 1 intervention - of which Recovery Factors is the first listed.
NCT04381793 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT04381793 about?
NCT04381793 is a clinical study titled "Treatment of CFS & Fibromyalgia With Recovery Factors". The study will explore if Recovery Factors improve symptoms in fibromyalgia and chronic fatigue syndrome
What is the current status of trial NCT04381793?
This trial is currently completed. It is a NA study. The enrollment target is 43 participants. The study started on 2019-05-20. Estimated completion is 2020-07-04.
What interventions are being tested in trial NCT04381793?
The interventions under investigation include: Recovery Factors (DIETARY_SUPPLEMENT).
Who is sponsoring clinical trial NCT04381793?
This trial is sponsored by Practitioners Alliance Network, which has 4 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT04381793's enrollment target sits among peer trials
43 1435th of 2000 higher than 565 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03726359 · 43 participants · Phase 1
Phase I Study of Fractionated Stereotactic Radiation Therapy
- NCT03850418 · 43 participants · Phase 2
Azacitidine and Chimerism in MDS or AML Patients After Allogeneic Stem Cell Transplant
- NCT04144023 · 43 participants · Phase 1
A Vaccine (H2NVAC) Before Surgery for the Treatment of HER2-Expressing Ductal Carcinoma In Situ
- NCT04176718 · 43 participants · Phase 2
Daratumumab, Carfilzomib, Pomalidomide, Dexamethasone In MM
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI